Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $364.5000 (-1.15%) ($364.3600 - $372.4300) on Wed. Jul. 13, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.23% (three month average) | RSI | 57 | Latest Price | $364.5000(-1.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.4% a day on average for past five trading days. | Weekly Trend | REGN advances 4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(62%) XLV(50%) XBI(46%) IVW(40%) IWF(40%) | Factors Impacting REGN price | REGN will decline at least -1.115% in a week (0% probabilities). VIXM(-9%) UUP(-7%) TLT(-7%) IPO(-6%) IBUY(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.115% (StdDev 2.23%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
5 Day Moving Average | $371.76(-1.95%) | 10 Day Moving Average | $365.03(-0.15%) | 20 Day Moving Average | $357.92(1.84%) | To recent high | -13.7% | To recent low | 10.1% | Market Cap | $38.647b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |